[link removed]


** 2021 Curing the Epilepsies Conference: The Epilepsy Community at an Inflection Point
------------------------------------------------------------
Key Points:
* The 2021 Curing the Epilepsies conference assembled diverse stakeholders from the epilepsy community to discuss the status of epilepsy research and transformative research priorities.

* During the 2021 conference, participants identified several key topics as indispensable for advancing epilepsy research and improving the lives of those impacted by epilepsy, including integrating epilepsy care and research, improving measurement and tracking of health outcomes, and reducing health disparities for underserved communities.

* In an editorial published after the conference ([link removed]) , members of the epilepsy advocacy community, co-led by CURE Epilepsy’s Chief Scientific Officer Dr. Laura Lubbers, proposed development of a National Plan to address the epilepsies. This plan would include a comprehensive strategy, the infrastructure, and the expanded partnerships to rapidly translate scientific discoveries into better health outcomes for people with epilepsy.

Deep Dive:

The Curing the Epilepsies conference has been held approximately every seven years since the first one in 2000. The initial conference was established with the help of CURE Epilepsy, with governmental funding agencies, professional societies, and other patient advocates also contributing. As in the past, the 2021 conference included stakeholders such as clinicians, researchers, and especially patients and caregivers, to review scientific discoveries and transformative research priorities with the ultimate goals of 1) curing epilepsy with no side effects and 2) preventing epilepsy in people at risk. Research progress, documented in an editorial ([link removed]) recently published in the journal Epilepsy Currents [1], has led to an enhanced understanding of:
* epileptogenesis, the processes by which epilepsy develops
* increased risk of premature death, especially from sudden unexpected death in epilepsy (SUDEP)
* epilepsy-associated comorbidities such as depression
* technologically based diagnostics, especially in neuroimaging and genetic testing
* non-pharmacological treatment options, particularly for surgery and implantable devices for treating seizures [1].

Continue Reading ([link removed])
Your support makes this research possible. ([link removed]) Our researchers’ important work continues through the current public health crisis and beyond thanks to generous donors who, like us, envision a world without epilepsy.
[link removed]
Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
[link removed]
[link removed]
[link removed]-
[link removed]
[link removed]

============================================================
Copyright © 2021 CURE Epilepsy, All rights reserved.
In the past you provided CURE Epilepsy your email address. Occasionally, you will receive updates from us about epilepsy research and news.

Our mailing address is:
CURE Epilepsy
420 Wabash Ave, Ste 650
Chicago, IL 60611
USA
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.

This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
CURE Epilepsy . 420 Wabash Ave, Ste 650 . Chicago, IL 60611 . USA